Metalloproteolytic receptor shedding…platelets “acting their age”

Platelets

Volumn 27, Issue 6, 2016, Pages 512-518

  Andrews, Robert K ^a   Gardiner, Elizabeth E ^b  

^a MONASH UNIVERSITY   (Australia)

^b Australian National University   (Australia)

Author keywords

Glycoprotein; metalloproteinase; platelet; thrombocytopenia

Indexed keywords

GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN VI; THROMBOCYTE RECEPTOR; ADHESION RECEPTOR; FIBRINOGEN RECEPTOR; PLATELET MEMBRANE GLYCOPROTEIN VI; THROMBIN RECEPTOR;

BLOOD CLOTTING; CIRCULATION; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; THROMBOCYTE LIFESPAN; ANIMAL; APOPTOSIS; CELL AGING; METABOLISM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BLOOD PLATELETS; CELL AGING; HUMANS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; PROTEOLYSIS;

EID: 84983239194     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2016.1212001     Document Type: Review

References (118)

1. B.Engelmann, M.Spannagl Activators, therapeutics and immunity-related aspects of thrombosis. Thromb Haemost 2014;111:568–569.
2. M.Leslie Beyond clotting:The powers of platelets. Science 2010;328:562–564.
3. M.T.Rondina, A.S.Weyrich, G.A.Zimmerman Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 2013;112:1506–1519.
4. R.J.Lin, V.Afshar-Kharghan, A.I.Schafer Paraneoplastic thrombocytosis:The secrets of tumor self-promotion. Blood 2014;124:184–187.
5. C.N.Jenne, P.Kubes Platelets in inflammation and infection. Platelets 2015;26:286–292.
6. K.R.Machlus, J.E.Italiano The incredible journey:From megakaryocyte development to platelet formation. J Cell Biol 2013;201:785–796.
7. E.C.Josefsson, D.L.Burnett, M.Lebois, M.A.Debrincat, M.J.White, K.J.Henley, R.M.Lane, D.Moujalled, S.P.Preston, L.A.O’Reilly, et al. Platelet production proceeds independently of the intrinsic and extrinsic apoptosis pathways. Nat Commun 2014;5:3455.
8. L.D.C.Casa, D.H.Deaton, D.N.Ku Role of high shear rate in thrombosis. J Vasc Surg 2015;61:1068–1080.
9. R.K.Andrews, M.C.Berndt Platelet physiology and thrombosis. Thromb Res 2004;114:447–453.
10. J.M.Cosemans, A.Angelillo-Scherrer, N.J.Mattheij, J.W.Heemskerk The effects of arterial flow on platelet activation, thrombus growth, and stabilization. Cardiovascul Res 2013;99:342–352.
11. S.M.de Witt, R.Verdoold, J.M.Cosemans, J.W.Heemskerk Insights into platelet-based control of coagulation. Thromb Res 2014;133(Suppl 2):S139–148.
12. S.P.Jackson Arterial thrombosis-insidious, unpredictable and deadly. Nat Med 2011;17:1423–1436.
13. M.Ungerer, G.Münch Novel antiplatelet drugs in clinical development. Thromb Haemostas 2013;110:868–875.
14. J.W.M.Cheng Updates in antiplatelet agents used in cardiovascular diseases. J Cardiovas Pharmacol Ther 2013;18:514–524.
15. G.Montalescot, M.S.Sabatine Oral dual antiplatelet therapy:What have we learnt from recent trials? Eur Heart J 2016;37:344–352.
16. B.J.McEwen The influence of diet and nutrients on platelet function. Semin Thromb Hemost 2014;40:214–226.
17. J.E.Geddings, N.Mackman New players in haemostasis and thrombosis. Thromb. Haemost. 2014;111:570–574.
18. J.F.Arthur, E.E.Gardiner, M.Matzaris, S.G.Taylor, L.Wijeyewickrema, Y.Ozaki, M.L.Kahn, R.K.Andrews, M.C.Berndt Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets. Thromb Haemost 2005;93:716–723.
19. E.E.Gardiner, R.K.Andrews Structure and function of platelet receptors initiating blood clotting. Adv Exp Med Biol 2014;844:263–275.
20. E.E.Gardiner, R.K.Andrews Platelet receptor expression and shedding:Glycoprotein Ib-IX-V and glycoprotein VI. Transf Med Rev 2014;28:56–60.
21. G.Berger, J.M.Masse, E.M.Cramer Alpha-granule membrane mirrors the platelet plasma membrane and contains the glycoproteins Ib, IX, and V. Blood 1996;87:1385–1395.
22. K.M.Hoffmeister The role of lectins and glycans in platelet clearance. J Thromb Haemost 2011;9(Suppl 1):35–43.
23. T.Tsuji, T.Osawa The carbohydrate moiety of human platelet glycocalicin:The structures of the major Asn-linked sugar chains. J Biochem 1987;101:241–249.
24. T.Tsuji, S.Tsunehisa, Y.Watanabe, K.Yamamoto, H.Tohyama, T.Osawa The carbohydrate moiety of human platelet glycocalicin. J Biol Chem 1983;258:6335–6339.
25. Wang Y, Jobe SM, Ding X, Choo H, Archer DR, Mi R, Ju T, Cummings RD. Platelet biogenesis and functions require correct protein O-glycosylation. Proc Natl Acad Sci USA 2012;109:16143–16148.
26. E.E.Gardiner, D.Karunakaran, Y.Shen, J.F.Arthur, R.K.Andrews, M.C.Berndt Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 2007;5:1530–1537.
27. R.K.Andrews, M.C.Berndt, J.A.López The glycoprotein Ib-IX-V complex. In A.D.Michelson, editor. Platelets. San Diego, CA (USA):Academic Press; 2006. p. 145–163.
28. S.-Z.Luo, X.Mo, V.Afshar-Kharghan, S.Srinivasan, J.A.Lopez, R.Li Glycoprotein Ibαforms disulfide bonds with 2 glycoprotein Ibβ subunits in the resting platelet. Blood 2007;109:603–609.
29. W.Zhang, W.Deng, L.Zhou, Y.Xu, W.Yang, X.Liang, Y.Wang, J.D.Kulman, X.F.Zhang, R.Li Identification of a juxtamembrane mechanosensitive domain in the platelet mechanosensor glycoprotein Ib-IX complex Blood 2015;125:562–569.
30. T.Yago, J.Lou, T.Wu, J.Yang, J.J.Miner, L.Coburn, J.A.Lopez, M.A.Cruz, J.F.Dong, L.V.McIntire, et al. Platelet glycoprotein Ibα forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest 2008;118:3195–3207.
31. M.H.Kroll, J.D.Hellums, L.V.McIntire, A.I.Schafer, J.L.Moake Platelets and shear stress Blood 1996;88:1525–1541.
32. R.K.Andrews, M.C.Berndt Bernard–soulier syndrome:An update. Semin Thromb Hemost 2013;39:656–662.
33. J.A.López, R.K.Andrews, V.Afshar-Kharghan, M.C.Berndt Bernard-Soulier syndrome. Blood 1998;91:4397–4418.
34. A.Corken, S.Russell, J.Dent, S.R.Post, J.Ware Platelet glycoprotein Ib-IX as a regulator of systemic inflammation. Arterio Thromb Vasc Biol 2014;34:996–1001.
35. B.Engelmann, S.Massberg Thrombosis as an intravascular effector of innate immunity. Nature reviews. Immunology 2013;13:34–45.
36. R.K.Andrews, S.J.Harris, T.McNally, M.C.Berndt Binding of purified 14-3-3 zeta signaling protein to discrete amino acid sequences within the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex. Biochemistry 1998;37:638–647.
37. N.Asazuma, Y.Ozaki, K.Satoh, Y.Yatomi, M.Handa, Y.Fujimura, S.Miura, S.Kume Glycoprotein Ib-von Willebrand factor interactions activate tyrosine kinases in human platelets. Blood 1997;90:4789–4798.
38. F.-T.Mu, R.K.Andrews, J.F.Arthur, A.D.Munday, S.L.Cranmer, S.P.Jackson, F.C.Stomski, A.F.Lopez, M.C.Berndt A functional 14-3-3ζ-independent association of PI3-kinase with glycoprotein Ibα, the major ligand-binding subunit of the platelet glycoprotein Ib-IX-V complex. Blood 2008;111:4580–4587.
39. A.D.Munday, M.C.Berndt, C.A.Mitchell Phosphoinositide 3-kinase forms a complex with platelet membrane glycoprotein Ib-IX-V complex and 14-3-3ζ. Blood 2000;96:577–584.
40. R.K.Andrews, A.D.Munday, C.A.Mitchell, M.C.Berndt Interaction of calmodulin with the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex. Blood 2001;98:681–687.
41. J.F.Arthur, Y.Shen, E.E.Gardiner, L.Coleman, D.Murphy, D.Kenny, R.K.Andrews, M.C.Berndt TNF receptor-associated factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets. J Thromb Haemost 2011;9:163–172.
42. R.K.Andrews, Y.Shen, E.E.Gardiner, J.F.Dong, J.A.Lopez, M.C.Berndt The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb Haemost 1999;82:357–364.
43. E.E.Gardiner, J.F.Arthur, Y.Shen, D.Karunakaran, L.A.Moore, J.S.Am Esch, R.K.Andrews, M.C.Berndt GPIbα-selective activation of platelets induces platelet signaling events comparable to GPVI activation events. Platelets 2010;21:244–252.
44. A.Garcia, T.M.Quinton, R.T.Dorsam, S.P.Kunapuli Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets. Blood 2005;106:3410–3414.
45. E.E.Gardiner A GPIb-IX-V complex signaling environment. J Thromb Haemost 2010;8:1075–1076.
46. Y.A.Senis, A.Mazharian, J.Mori Src family kinases:At the forefront of platelet activation. Blood 2014;124:2013–2024.
47. B.Nieswandt, S.P.Watson Platelet-collagen interaction:Is GPVI the central receptor? Blood 2003;102:449–461.
48. Y.Ozaki, K.Suzuki-Inoue, O.Inoue Novel interactions in platelet biology:CLEC-2/podoplanin and laminin/GPVI. J Thromb Haemost 2009;7:191–194.
49. E.Mammadova-Bach, V.Ollivier, S.Loyau, M.Schaff, B.Dumont, R.Favier, G.Freyburger, V.Latger-Cannard, B.Nieswandt, C.Gachet, et al. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood 2015;126:683–691.
50. A.Bultmann, Z.Li, S.Wagner, M.Peluso, T.Schonberger, C.Weis, I.Konrad, K.Stellos, S.Massberg, B.Nieswandt, et al. Impact of glycoprotein VI and platelet adhesion on atherosclerosis:A possible role of fibronectin. J Mol Cell Cardiol 2010;49:532–542.
51. O.Inoue, K.Suzuki-Inoue, O.J.T.McCarty, M.Moroi, Z.M.Ruggeri, T.J.Kunicki, Y.Ozaki, S.P.Watson Laminin stimulates spreading of platelets through integrin α6β1-dependent activation of GPVI. Blood 2006;107:1405–1412.
52. O.M.Alshehri, C.E.Hughes, S.Montague, S.K.Watson, J.Frampton, M.Bender, S.P.Watson Fibrin activates GPVI in human and mouse platelets. Blood 2015;126:1601–1608.
53. J.F.Arthur, Y.Shen, M.L.Kahn, M.C.Berndt, R.K.Andrews, E.E.Gardiner Ligand binding rapidly induces disulfide-dependent dimerization of glycoprotein VI on the platelet plasma membrane. J Biol Chem 2007;282:30434–30441.
54. S.M.Jung, M.Moroi, K.Soejima, T.Nakagaki, Y.Miura, M.C.Berndt, E.E.Gardiner, J.M.Howes, N.Pugh, D.Bihan, et al. Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood. J Biol Chem 2012;287:30000–30013.
55. K.Horii, M.L.Kahn, A.B.Herr Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI. Blood 2006;108:936–942.
56. T.Bori-Sanz, K.S.Inoue, M.C.Berndt, S.P.Watson, D.Tulasne Delineation of the region in the glycoprotein VI tail required for association with the Fc receptor gamma-chain. J Biol Chem 2003;278:35914–35922.
57. S.M.Jung, M.Moroi Platelet glycoprotein VI. In:A.B.Sigalov, editor. Multichain immune recognition receptor signaling. New York:Springer, 2008. p. 53–63.
58. J.F.Arthur, J.Qiao, Y.Shen, A.K.Davis, E.Dunne, M.C.Berndt, E.E.Gardiner, R.K.Andrews ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and -independent pathways. J Thromb Haemost 2012;10:1133–1141.
59. R.H.Lee, W.Bergmeier Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development. J Thromb Haemost 2016;14:645–654.
60. H.Chen, D.Locke, Y.Liu, C.Liu, M.L.Kahn The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J Biol Chem 2002;277:3011–3019.
61. C.G.Ruan, X.P.Du, X.D.Xi, P.A.Castaldi, M.C.Berndt A murine antiglycoprotein Ib complex monoclonal antibody, SZ2, inhibits platelet aggregation induced by both ristocetin and collagen. Blood 1987;69:570–577.
62. R.K.Andrews, D.Karunakaran, E.E.Gardiner, M.C.Berndt Platelet receptor proteolysis:a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 2007;27:1511–1520.
63. A.N.Wicki, K.J.Clemetson Structure and function of platelet membrane glycoproteins Ib and V. Effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin. Eur J Biochem 1985;153:1–11.
64. K.A.Aziz, J.C.Cawley, A.S.Kamiguti, M.Zuzel Degradation of platelet glycoprotein Ib by elastase released from primed neutrophils. Br J Haematol 1995;91:46–54.
65. J.P.Greenberg, M.A.Packham, M.A.Guccione, M.L.Rand, H.J.Reimers, J.F.Mustard Survival of rabbit platelets treated in vitro with chymotrypsin, plasmin, trypsin, or neuraminidase. Blood 1979;53:916–927.
66. E.E.Gardiner, J.F.Arthur, M.L.Kahn, M.C.Berndt, R.K.Andrews, (2004) Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood 104:3611–3617.
67. P.Seizer, A.E.May Platelets and matrix metalloproteinases. Thromb Haemost 2013;110:903–909.
68. E.E.Gardiner, D.Karunakaran, J.F.Arthur, F.T.Mu, M.S.Powell, R.I.Baker, P.M.Hogarth, M.L.Kahn, R.K.Andrews, M.C.Berndt Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors:De-ITAM-izing FcγRIIa. Blood 2008;111:165–174.
69. B.S.Coller, E.Kalomiris, M.Steinberg, L.E.Scudder Evidence that glycocalicin circulates in normal plasma. J Clin Invest 1984;73:794–799.
70. J.H.Beer, L.Buchi, B.Steiner Glycocalicin:a new assay–the normal plasma levels and its potential usefulness in selected diseases. Blood 1994;83:691–702.
71. Y.Li, J.Brazzell, A.Herrera, B.Walcheck ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding. Blood 2006;108:2275–2279.
72. W.Bergmeier, C.L.Piffath, G.Cheng, V.S.Dole, Y.Zhang, U.H.von Andrian, D.D.Wagner Tumor necrosis factorα–converting enzyme (ADAM17) mediates GPIbα shedding from platelets in vitro and in vivo. Circ Res 2004;95:677–683.
73. M.Forestier, M.Al-Tamimi, E.E.Gardiner, C.Hermann, S.C.Meyer, J.H.Beer Diesel exhaust particles impair platelet response to collagen and are associated with GPIbα shedding. Toxicology In Vitro 2012;26:930–938.
74. S.M.Schoenwaelder, K.E.Jarman, E.E.Gardiner, M.Hua, J.Qiao, M.J.White, E.C.Josefsson, I.Alwis, A.Ono, A.Willcox, et al. Bcl-xL inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood 2011;118:1663–1674.
75. M.M.Tana, X.Zhao, A.Bradshaw, M.S.Moon, S.Page, T.Turner, E.Rivera, D.E.Kleiner, T.Heller Factors associated with the platelet count in patients with chronic hepatitis C. Thromb Res 2015;135:823–828.
76. S.J.Barsam, B.Psaila, M.Forestier, L.K.Page, P.A.Sloane, J.T.Geyer, G.O.Villarica, M.M.Ruisi, T.B.Gernsheimer, J.H.Beer, et al. Platelet production and platelet destruction:Assessing mechanisms of treatment effect in immune thrombocytopenia (ITP). Blood 2011;117:5723–5732.
77. M.Al-Tamimi, C.Tan, J.Qiao, G.J.Pennings, A.Javadzadegan, A.S.C.Yong, J.F.Arthur, A.K.Davis, J.Jing, F.T.Mu, et al. Pathological shear triggers shedding of vascular receptors:A novel mechanism for downregulation of platelet glycoprotein (GP)VI in stenosed coronary vessels. Blood 2012;119:4311–4320.
78. A.Facey, I.Pinar, J.F.Arthur, J.Qiao, J.Jing, B.Mado, J.Carberry, R.K.Andrews, E.E.Gardiner A-Disintegrin-And-Metalloproteinase (ADAM)10 activity on resting and activated platelets. Biochemistry 2016;55:1187–1194.
79. U.Schaff, P.E.Mattila, S.I.Simon, B.Walcheck Neutrophil adhesion to E-selectin under shear promotes the redistribution and co-clustering of ADAM17 and its proteolytic substrate L-selectin. J Leuk Biol 2008;83:99–105.
80. E.J.Haining, J.Yang, R.L.Bailey, K.Khan, R.Collier, S.Tsai, S.P.Watson, J.Frampton, P.Garcia, M.G.Tomlinson The TspanC8 subgroup of tetraspanins interacts with A disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression. J Biol Chem 2012;287:39753–39765.
81. M.B.Protty, N.A.Watkins, D.Colombo, S.G.Thomas, V.L.Heath, J.M.Herbert, R.Bicknell, Y.A.Senis, L.K.Ashman, F.Berditchevski, et al. Identification of Tspan9 as a novel platelet tetraspanin and the collagen receptor GPVI as a component of tetraspanin microdomains. Biochem J 2009;417:391–400.
82. E.Dornier, F.Coumailleau, J.F.Ottavi, J.Moretti, C.Boucheix, P.Mauduit, F.Schweisguth, E.Rubinstein TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals. J Cell Biol 2012;199:481–496.
83. T.Maretzky, D.R.McIlwain, P.D.Issuree, X.Li, J.Malapeira, S.Amin, P.A.Lang, T.W.Mak, C.P.Blobel iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding. Proc Natl Acad Sci USA 2013;110:11433–11438.
84. S.Kruss, L.Erpenbeck, K.Amschler, T.A.Mundinger, H.Boehm, H.-J.Helms, T.Friede, R.K.Andrews, M.P.Schön, J.P.Spatz Adhesion maturation of neutrophils on nanoscopically presented platelet glycoprotein Ibα. ACS Nano 2013;7:9984–9996.
85. M.Crook Sialic acid:Its importance to platelet function in health and disease. Platelets 1991;2:1–10.
86. M.Canault, D.Duerschmied, A.Brill, L.Stefanini, D.Schatzberg, S.M.Cifuni, W.Bergmeier, D.D.Wagner p38 mitogen-activated protein kinase activation during platelet storage:Consequences for platelet recovery and hemostatic function in vivo. Blood 2010;115:1835–1842.
87. M.C.Berndt, E.E.Gardiner Biomarkers of vascular disease:GPVI shedding. Hematol Educ 2010;4:57–62.
88. M.Al-Tamimi, J.F.Arthur, E.E.Gardiner, R.K.Andrews Focusing on plasma glycoprotein VI. Thromb Haemost 2012;107:648–655.
89. J.Qiao, M.Al-Tamimi, R.I.Baker, R.K.Andrews, E.E.Gardiner The platelet Fc receptor, FcγRIIa. Immunol Rev 2015;268:241–252.
90. K.Kaushansky Historical review:Megakaryopoiesis and thrombopoiesis. Blood 2008;111:981–986.
91. R.Grozovsky, S.Giannini, H.Falet, K.M.Hoffmeister Regulating billions of blood platelets:Glycans and beyond. Blood 2015;126:1877–1884.
92. D.J.Kuter Milestones in understanding platelet production:A historical overview. Br J Haematol 2014;165:248–258.
93. B.T.Kile Aging platelets stimulate TPO production. Nat Med 2015;21:11–12.
94. Q.Feng, N.Shabrani, J.N.Thon, H.Huo, A.Thiel, K.R.Machlus, K.Kim, J.Brooks, F.Li, C.Luo, et al. Scalable generation of universal platelets from human induced pluripotent stem cells. Stem Cell Reports 2014;3:817–831.
95. C.Dunois-Larde, C.Capron, S.Fichelson, T.Bauer, E.Cramer-Borde, D.Baruch Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 2009;114:1875–1883.
96. J.N.Thon, L.Mazutis, S.Wu, J.L.Sylman, A.Ehrlicher, K.R.Machlus, Q.Feng, S.Lu, R.Lanza, K.B.Neeves, et al. Platelet bioreactor-on-a-chip. Blood 2014;124:1857–1867.
97. T.Junt, H.Schulze, Z.Chen, S.Massberg, T.Goerge, A.Krueger, D.D.Wagner, T.Graf, J.E.ItalianoJr., R.A.Shivdasani, et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007;317:1767–1770.
98. A.Robert, L.Boyer, N.Pineault Glycoprotein Ibα receptor instability is associated with loss of quality in platelets produced in culture. Stem Cells Dev 2011;20:379–390.
99. H.Nishikii, K.Eto, N.Tamura, K.Hattori, B.Heissig, T.Kanaji, A.Sawaguchi, S.Goto, J.Ware, H.Nakauchi Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells. J Exp Med 2008;205:1917–1927.
100. A.J.G.Jansen, E.C.Josefsson, V.Rumjantseva, Q.P.Liu, H.Falet, W.Bergmeier, S.M.Cifuni, R.Sackstein, U.H.von Andrian, D.D.Wagner, et al. Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice. Blood 2012;119:1263–1273.
101. R.Grozovsky, A.J.Begonja, K.Liu, G.Visner, J.H.Hartwig, H.Falet, K.M.Hoffmeister The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nature Med 2015;21:47–54.
102. L.Shao, Y.Wu, H.Zhou, P.Qin, H.Ni, J.Peng, M.Hou Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody. Platelets 2015;26:495–497.
103. A.D.Michelson, R.K.Andrews, M.C.Berndt The GPIb-IX-V complex. In A.D.Michelson, editor. Platelets. San Diego, CA (USA):Academic Press; 2013. p. 195–213.
104. A.L.Frelinger, R.F.Grace, A.J.Gerrits, M.A.Berny-Lang, T.Brown, S.L.Carmichael, E.J.Neufeld, A.D.Michelson Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP. Blood 2015;126:873–879.
105. K.D.Mason, M.R.Carpinelli, J.I.Fletcher, J.E.Collinge, A.A.Hilton, S.Ellis, P.N.Kelly, P.G.Ekert, D.Metcalf, A.W.Roberts, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007;128:1173–1186.
106. B.T.Kile The role of apoptosis in megakaryocytes and platelets. Br J Haematol 2014;165:217–226.
107. S.Stivala, M.F.Reiner, C.Lohmann, T.F.Lüscher, C.M.Matter, J.H.Beer Dietary α-linolenic acid increases the platelet count in ApoE−/− mice by reducing clearance. Blood 2013;122:1026–1033.
108. Y.Cadroy, S.R.Hanson, A.B.Kelly, U.M.Marzec, B.L.Evatt, T.J.Kunicki, R.R.Montgomery, L.A.Harker Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates. Blood 1994;83:3218–3224.
109. V.Kiefel, S.Santoso, E.Kaufmann, C.Mueller-Eckhardt Autoantibodies against platelet glycoprotein Ib/IX:A frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol 1991;79:256–262.
110. B.Nieswandt, W.Bergmeier, K.Rackebrandt, J.E.Gessner, H.Zirngibl Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood 2000;96:2520–2527.
111. J.Peng, S.H.Ma, J.Liu, Y.Hou, X.M.Liu, T.Niu, R.R.Xu, C.S.Guo, X.M.Wang, Y.F.Cheng, H.Ni, M.Hou Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia:A multicenter cohort study. J Thromb Haemost 2014;12:497–504.
112. M.L.Webster, E.Sayeh, M.Crow, P.Chen, B.Nieswandt, J.Freedman, H.Ni Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GPIIbIIIa versus GPIbα antibodies. Blood 2006;108:943–946.
113. X.Liang, A.K.Syed, S.R.Russell, J.Ware, R.Li Dimerization of glycoprotein Ibα is not sufficient to induce platelet clearance. J Thromb Haemost 2016;14(2):381–386.
114. V.Rumjantseva, P.K.Grewal, H.H.Wandall, E.C.Josefsson, A.L.Sorensen, G.Larson, J.D.Marth, J.H.Hartwig, K.M.Hoffmeister Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nature Med 2009;15:1273–1280.
115. R.T.Urbanus, D.E.van der Wal, C.A.Koekman, A.Huisman, D.J.van den Heuvel, H.C.Gerritsen, H.Deckmyn, J.-W.N.Akkerman, R.E.G.Schutgens, E.Gitz Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ibα and FcγRIIa in immune thrombocytopenia. Haematologia 2013;98:e70–e72.
116. B.Alioglu, A.Tasar, C.Ozen, B.Selver, Y.Dallar An experience of oseltamivir phosphate (tamiflu) in a pediatric patient with chronic idiopathic thrombocytopenic purpura:A case report. Pathophysiol Haemost Thromb 2010;37:55–58.
117. J.Li, D.E.van der Wal, G.Zhu, M.Xu, I.Yougbare, L.Ma, B.Vadasz, N.Carrim, R.Grozovsky, M.Ruan, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Commun 2015;6:e7737.
118. Alioglu B, Tasar A, Ozen C, Selver B, Dallar Y. An experience of oseltamivir phosphate (tamiflu) in a pediatric patient with chronic idiopathic thrombocytopenic purpura:A case report. Pathophysiol Haemost Thromb 2010;37:55–58.